191 related articles for article (PubMed ID: 27666870)
1. Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer.
Stanciu AE; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2016 Dec; 76(8):626-631. PubMed ID: 27666870
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
[TBL] [Abstract][Full Text] [Related]
3. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
5. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
6. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B
Swiss Med Wkly; 2005 Sep; 135(37-38):549-54. PubMed ID: 16333765
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
[TBL] [Abstract][Full Text] [Related]
9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
10. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
[TBL] [Abstract][Full Text] [Related]
12. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
15. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
Kouloubinis A; Kaklamanis L; Ziras N; Sofroniadou S; Makaritsis K; Adamopoulos S; Revela I; Athanasiou A; Mavroudis D; Georgoulias V
Int J Cardiol; 2007 Nov; 122(3):195-201. PubMed ID: 17289172
[TBL] [Abstract][Full Text] [Related]
16. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
Melander O; Frandsen E; Magnusson M; Grubb A; Jovinge S; Groop L
J Intern Med; 2005 Mar; 257(3):281-8. PubMed ID: 15715685
[TBL] [Abstract][Full Text] [Related]
17. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Endresen K; Bjørnerheim R; Hall C
Clin Cardiol; 2002 Apr; 25(4):174-80. PubMed ID: 12000075
[TBL] [Abstract][Full Text] [Related]
18. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
[No Abstract] [Full Text] [Related]
19. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]